Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as ...

The MarketWatch News Department was not involved in the creation of this content.-- Rezurock(R) (belumosudil tablets) now listed for public reimbursement, offering access to adult ...

Picture this: you’re surviving cancer, chemotherapy, radiation, immunosuppression, and a blood stem cell transplant, and you haven’t left the hospital in weeks. Yet, somehow, you have what feels and ...

MaaT Pharma Announces Positive Phase 3 Results Evaluating Xervyteg® (MaaT013) in aGvHD Selected for Oral Presentation at ASH Congress 2025.

A combination of blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely ...

Jimmy Kimmel’s longtime bandleader, Cleto Escobedo III, died because his heart couldn't pump enough blood to keep him alive, ...

Paris, October 17, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a negative opinion on the marketing authorisation application for Rezurock ...

Introduction: The occurrence of monoclonal gammopathies (MG) and oligoclonal (two or more monoclonal proteins) gammopathies (OG) might be triggered by some factors, such as immune recovery following ...

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...

Sanofi is pleased to announce that Quebec has added Rezurock® (belumosudil tablets) to the list of medications covered by the ...